Source: Cancer Biotherapy and Radiopharmaceuticals. Unidade: FMRP
Subjects: OSTEOSSARCOMA, RADIOTERAPIA
ABNT
BRASSESCO, María Sol et al. Activator protein-1 inhibition by 3-[(dodecylthiocarbonyl) methyl]-glutamaride impairs invasion and radiosensitizes osteosarcoma cells in vitro. Cancer Biotherapy and Radiopharmaceuticals, v. 28, n. 4, p. 351-358, 2013Tradução . . Disponível em: https://doi.org/10.1089/cbr.2012.1305. Acesso em: 17 out. 2024.APA
Brassesco, M. S., Pezuk, J. A., Oliveira, J. C. de, Valera, E. T., Oliveira, H. F. de, Scrideli, C. A., et al. (2013). Activator protein-1 inhibition by 3-[(dodecylthiocarbonyl) methyl]-glutamaride impairs invasion and radiosensitizes osteosarcoma cells in vitro. Cancer Biotherapy and Radiopharmaceuticals, 28( 4), 351-358. doi:10.1089/cbr.2012.1305NLM
Brassesco MS, Pezuk JA, Oliveira JC de, Valera ET, Oliveira HF de, Scrideli CA, Umezawa K, Tone LG. Activator protein-1 inhibition by 3-[(dodecylthiocarbonyl) methyl]-glutamaride impairs invasion and radiosensitizes osteosarcoma cells in vitro [Internet]. Cancer Biotherapy and Radiopharmaceuticals. 2013 ; 28( 4): 351-358.[citado 2024 out. 17 ] Available from: https://doi.org/10.1089/cbr.2012.1305Vancouver
Brassesco MS, Pezuk JA, Oliveira JC de, Valera ET, Oliveira HF de, Scrideli CA, Umezawa K, Tone LG. Activator protein-1 inhibition by 3-[(dodecylthiocarbonyl) methyl]-glutamaride impairs invasion and radiosensitizes osteosarcoma cells in vitro [Internet]. Cancer Biotherapy and Radiopharmaceuticals. 2013 ; 28( 4): 351-358.[citado 2024 out. 17 ] Available from: https://doi.org/10.1089/cbr.2012.1305